Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jo El J Schultz

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
American Journal of Physiology. Heart and Circulatory Physiology|February 3, 2009
Hypertensive state, independent of hypertrophy, exhibits an attenuated decrease in systolic function on cardiac kappa-opioid receptor stimulationCraig Bolte, Gilbert Newman, Jo El J Schultz
Journal of Molecular and Cellular Cardiology|July 4, 2009
Kappa and delta opioid receptor signaling is augmented in the failing heartCraig Bolte, Gilbert Newman, Jo El J Schultz
The Journal of Biological Chemistry|October 16, 2004
The alpha 1 isoform of Na,K-ATPase regulates cardiac contractility and functionally interacts and co-localizes with the Na/Ca exchanger in heartIva Dostanic, Jo El J Schultz, John N Lorenz, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|September 28, 2007
Remote preconditioning-endocrine factors in organ protection against ischemic injuryCraig S Bolte, Siyun Liao, Garrett J Gross, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 26, 2005
Cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2 is mediated by the MAPK cascadeStacey L House, Kevin Branch, Gilbert Newman, et al.
Journal of Proteome Research|September 11, 2013
Quantitative phosphoproteomics using acetone-based peptide labeling: method evaluation and application to a cardiac ischemia/reperfusion modelAruna B Wijeratne, Janet R Manning, Jo El J Schultz, et al.
Journal of Molecular and Cellular Cardiology|December 8, 2006
The cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: the role of JNK signalingSiyun Liao, Darius Porter, Alana Scott, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|September 6, 2008
Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and diseaseSiyun Liao, Janet Bodmer, Daniel Pietras, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 6, 2007
The protein kinase C pathway mediates cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2Stacey L House, Susan J Melhorn, Gilbert Newman, et al.
Growth Factors (Chur, Switzerland)|June 5, 2020
Limb functional recovery is impaired in fibroblast growth factor-2 (FGF2) deficient mice despite chronic ischaemia-induced vascular growthAdeola Adeyemo, Christopher Johnson, Andrew Stiene, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
American Journal of Physiology. Heart and Circulatory Physiology|February 3, 2009
Hypertensive state, independent of hypertrophy, exhibits an attenuated decrease in systolic function on cardiac kappa-opioid receptor stimulationCraig Bolte, Gilbert Newman, Jo El J Schultz
Journal of Molecular and Cellular Cardiology|July 4, 2009
Kappa and delta opioid receptor signaling is augmented in the failing heartCraig Bolte, Gilbert Newman, Jo El J Schultz
The Journal of Biological Chemistry|October 16, 2004
The alpha 1 isoform of Na,K-ATPase regulates cardiac contractility and functionally interacts and co-localizes with the Na/Ca exchanger in heartIva Dostanic, Jo El J Schultz, John N Lorenz, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|September 28, 2007
Remote preconditioning-endocrine factors in organ protection against ischemic injuryCraig S Bolte, Siyun Liao, Garrett J Gross, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 26, 2005
Cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2 is mediated by the MAPK cascadeStacey L House, Kevin Branch, Gilbert Newman, et al.
Journal of Proteome Research|September 11, 2013
Quantitative phosphoproteomics using acetone-based peptide labeling: method evaluation and application to a cardiac ischemia/reperfusion modelAruna B Wijeratne, Janet R Manning, Jo El J Schultz, et al.
Journal of Molecular and Cellular Cardiology|December 8, 2006
The cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: the role of JNK signalingSiyun Liao, Darius Porter, Alana Scott, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|September 6, 2008
Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and diseaseSiyun Liao, Janet Bodmer, Daniel Pietras, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 6, 2007
The protein kinase C pathway mediates cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2Stacey L House, Susan J Melhorn, Gilbert Newman, et al.
Growth Factors (Chur, Switzerland)|June 5, 2020
Limb functional recovery is impaired in fibroblast growth factor-2 (FGF2) deficient mice despite chronic ischaemia-induced vascular growthAdeola Adeyemo, Christopher Johnson, Andrew Stiene, et al.
Pageof 3